期刊文献+

维A酸隐形泡囊的制备及其体外性质的研究 被引量:1

Preparation of Retinal acid stealth niosomes and evaluation of their characteristics in vitro
原文传递
导出
摘要 目的制备维A酸隐形泡囊并考察其理化、体外生物学性质。方法考察隐形泡囊的形态和粒径分布,经凝胶色谱分离,再用分光光度法测定维A酸的含量,计算包封率,测定冻干品的载药量;以普通泡囊的结果作为对照,考察巨噬细胞摄取率和癌细胞生长抑制率。结果维A酸泡囊和隐形泡囊的平均粒径分别为33、41μm,包封率分别为91.4%、93.10%,载药量分别为3.15%、2.82%。隐形泡囊规避巨噬细胞的吞噬能力提高26%以上;隐形泡囊与原药对癌细胞的生长抑制率相同。结论所制维A酸隐形泡囊的包封率高、操作方法简便;隐形泡囊既可保持较高抗癌活性,又能规避吞噬。 OBJECTIVE To prepare Retinal acid stealth niosomes and evaluate their physicochemical and biological properties in vitro. METHODS The technology for preparation of stealth noisomes was optimized, and their morphology and particle sizes were evaluated. The entrapment efficiency (after separation by gel chromatography) and drug loading ratio of the lyophilized stealth niosomes were determined by UV spectrophotometry. The uptaken ratio of the stealth niosomes by MPM cells and the inhibition of carcinoma cell growth were studied as well, with the normal niosomes as the control. RESULTS The average sizes of the niosomes and the stealth niosomes were 33 and 41 um, respectively. The entrapment efficiencies, determined after separation by gel chromatography, were 91.4% and 93.1%, and drug loading ratios were 3.15 % and 2.82%, respectively. The uptaken ratio of the stealth niosomes by MPM cells decreased more than 26% , and the inhibition rate of carcinoma cell growth was the same as the ordinary drug. CONCLU- SION The Retinal acid stealth niosomes with high entrapment efficiency were easy to prepare based on simple procedures and showed high antitumor efficiency with evasion of phagocytosis by MPM cells.
出处 《华西药学杂志》 CAS CSCD 北大核心 2009年第3期238-240,共3页 West China Journal of Pharmaceutical Sciences
基金 国家自然科学基金资助项目(批准号:30572262)
关键词 维A酸 隐形泡囊 理化性质 抗癌活性 规避吞噬 Retinal acid Stealth niosomes Physical and chemical properties Anti - tumor efficiency Evasion of phagocytosis
  • 相关文献

参考文献8

  • 1Sun SY,Yue P,Dauson MI,et al.Different effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung-carcinoma cells[J].Cancer Res.1997,57(21):4931-4939.
  • 2唐跃年,胡松浩,孙朝荣,毛五妹.全反式维甲酸的药理学特点[J].医药导报,2002,21(6):381-382. 被引量:11
  • 3Fang JY,Yu SY,Wu PC,et al.In vitro skin permeation of estradiol from various proniosome formulation[J].Int J Pharm,2001,215:91-99.
  • 4Lu B,Zhang JQ,Yang H.Lung-targeting microspheres of carboplmin[J].Int J Pharm,2003,265:1-11.
  • 5Gref R,Luck M,Quellce P,et al.Stealth corona-core nanoparticles-surface modified by polyethylene glycol:influences of the corona PEG chain length and surface density and of the core composition on phagocytic uptake and plasma protein adsorption[J].Colloid Surf B Biointerfaces,2000,18(3-4):301-309.
  • 6中华人民共和国国家药典委员会.中国药典[S].二部.北京:化学工业出版社,2005.661-662.
  • 7许向阳,周建平,李玲,施丹霞,卢是玥,杨洁,霍美蓉.阿霉素高聚物胶束的制备及其体外抗肿瘤活性研究[J].中国药学杂志,2008,43(7):514-518. 被引量:9
  • 8陈永,杨红,陆彬,李玫,宗太丽.肺靶向顺铂泡囊的研制与体外性质的评价[J].华西药学杂志,2008,23(2):129-132. 被引量:8

二级参考文献20

  • 1李革新,姚书杰,陆春伟,金亚平,孙贵范.顺铂肾毒性的实验研究[J].中国工业医学杂志,2004,17(3):186-187. 被引量:9
  • 2张明,侯世祥,龚涛,程宇慧,廖工铁.肺靶向顺铂白蛋白微球含量的衍生化测定法[J].中国药学杂志,1994,29(6):355-357. 被引量:4
  • 3许向阳,周建平,李玲,卢是玥,杨洁.N-正辛基-N′-琥珀酰基壳聚糖的制备及其对4种肿瘤细胞的亲和性[J].中国新药与临床杂志,2007,26(5):355-359. 被引量:11
  • 4GREISH K, SAWA T, FANG J, et al. SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours [ J ]. J Controlled Release ,2004,97 (2) :219-230.
  • 5NGIMHUANG J, FURUKAWA J I, SATOH T, et al. Synthesis of a novel polymeric surfactant by reductive N-alkylation of chitosan with 3-O-dodecyl-d-glucose [ J ]. Polymer, 2004, 45 ( 3 ) : 837-841.
  • 6SON Y J, JANG J S, CHO Y W, et al. Biodistribution and antitumor efficacy of doxorubiein loaded glycol-ehitosan nanoaggregates by EPR effect[J]. J Controlled Release, 2003, 91 ( 1- 2) :135-145.
  • 7MITRA S, GAUR P C, GHOSH P C, et al. Tumour targeted delivery of encapsulated dextran doxorubicin conjugate using chitosan nanoparticles as carrier[J]. J CuntruUed Release, 2001, 74 (1-3) :317-323.
  • 8PARK J H, CHO Y W, CHUNG H, et al. Synthesis and characterization of sugar-bearing chitosan derivatives : aqueous solubility and biodegradability [J] . Biomacromolecules, 2003, 4 ( 4 ) : 1087-1091.
  • 9KHOR E, LIM L Y. lmplantable applications of chitin and chitosan [J]. Biomaterials, 2003, 24 ( 13 ) :2339-2349.
  • 10YOUNG I J, JAE W N, HYUN C L, et al. Adriamycin release from flower-type polymeric micelle based on star-block copolymer composed of poly(γ,-benzyl L-glutamate) as the bydrophobic part and poly( ethylene oxide) as the hydrophilic part[ J]. Int J Pharmaceutics, 1999, 188( 1 ) :49-58.

共引文献24

同被引文献6

  • 1杨红,陈华黎,刘赟赟,卓国清,赵晨,黄嘉兰.维A酸贴剂的体外透皮扩散研究[J].中国药师,2007,10(7):666-668. 被引量:3
  • 2Njar VC, Gediya L, Purushottamachar P, et al. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases [J]. Bioorg Med Chem,2006,14 (13): 4323-4340.
  • 3Soo-Jeong Lima, Mi-Kyung Leeb, Chong-Kook Kim. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders [J]. J Control Re lease,2004,100 ( 1 ) :53-61.
  • 4Manconi M,Sinico C, Valenti D,et al. Niosomes as carriers for tretinoin. Ⅰ. Preparmion and properties [J]. Int J Pharm,2002, 234 (1 2):237-248.
  • 5Manosroi A, Kongkaneramit L, Manosroi J. Stability and transdermal absorption of topical amphotericin B liposome formulations [J]. Int J of Pharm,2004,270 (1-2):179-186.
  • 6陆彬.作为载药系统的聚合物胶束和泡囊的研究[J].河南大学学报(医学版),2008,27(1):1-7. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部